August 23 (SeeNews) - Bulgarian medical consumables producer Etropal [BUL:5EO] said on Friday that its consolidated net profit after minority interest remained flattish year-on-year at just 22,000 levs ($12,000/11,000 euro), slightly down from 38,000 levs in the same period of 2018.
Etropal's revenue fell to 4.1 million levs in the January-June period of 2019 from 4.4 million levs in the comparable period of last year, the company said in an interim financial statement.
Operating expenses decreased to 4.1 million levs in the review period from 4.4 million levs the year before, as expenses for materials fell to 2.3 million levs from 2.6 million levs.
The company's assets rose to 14.5 million levs at the end of June from 12.6 million levs a year earlier, due to an increase in inventory and trade receivables.
Etropal consolidates the results of its majority-owned unit Etropal Trade.
(1 euro = 1.95583 levs)